Although TSPO-based imaging has limitations due to its expression in other myeloid cells [64], newer ligands like [11C]DPA-713 have confirmed widespread microglial activation during the early stages of PD, implicating neuroinflammation as a pathogenic factor [65]. Here, TSPO is linked to Parkinson disease.